Biofourmis
AI-Powered Predictive Virtual Care
Boston, Massachusetts, Singapore
Biofourmis is a Singapore-based digital therapeutics company that uses continuous monitoring of connected medical devices to manage chronic conditions. It focuses on heart conditions and has demonstrated significant improvements in patient outcomes and cost reduction.
How We Help
Problem Statement
Healthcare organizations face challenges with suboptimal patient outcomes, high hospital readmission rates, inefficient chronic disease management, and escalating costs. Biofourmis addresses these by enabling personalized, predictive in-home care and accelerating drug development.
Core Technology
digital therapeutics through continuous monitoring of connected medical devices
Key Differentiators
Detects heart failure decompensation 21 hours earlier than standard care
Clinical Focus
ambulatory physiologic monitoring
Target Customers
["Hospitals", "Health systems", "Payers", "Biopharmaceutical companies"]
Product Stage
Mature
Company Info
- Business Model
- B2B, SaaS
- Founded
- 2015
- Total Funding
- 455,000,000
- Website
- www.biofourmis.com
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of Biofourmis?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.